Electrical storm: Clinical manifestations and management

Minerva Medica

Volumn 98, Issue 5, 2007, Pages 489-501

  Littmann, L ^a   Rennyson, S L ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Arrhythmia, genetics; Implanted cardioverter defibrillator; Tachycardia, ventricular; Ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; DENOPAMINE; ESMOLOL; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; MEXILETINE; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL;

CARDIOVERSION; CATHETER ABLATION; CLINICAL EVALUATION; CLINICAL FEATURE; CONTINUOUS INFUSION; DEFIBRILLATOR; DISEASE ASSOCIATION; DRUG DOSE TITRATION; ELECTRICAL STORM; EMERGENCY MEDICINE; EMOTION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTENSIVE CARE; LOADING DRUG DOSE; PACEMAKER; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REVIEW;

BRUGADA SYNDROME; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RECURRENCE; SODIUM CHANNEL BLOCKERS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 36949020852     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Kowey PR. An overview of antiarrhythmic drug management of electrical storm. Can J Cardiol 1996;12(Suppl B):3B-8B.
2. Dorian P, Cass D. An overview of the management of electrical storm. Can J Cardiol 1997;13(Suppl A):13A-17A.
3. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000;102:742-7.
4. Sukhija R, Mehta V, Leonardi M, Mehta JL. Implantable cardioverter defibrillators for prevention of sudden cardiac death. Clin Cardiol 2007;30:3-8.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
6. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006;97:1255-61.
7. Villacastín J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996;93:753-62.
8. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-15.
9. Bänsch D, Böcker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-73.
10. Exner DV, Pinski SL, Wyse G, Renfroe EG, Follmann D, Gold M et al. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 2001;103:2066-71.
11. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15:1265-70.
12. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005;7:184-92.
13. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-7.
14. Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 2006;27:3027-32.
15. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000;2:263-9.
16. Jordaens LJ, Mekel JM. Electrical storm in the ICD era. Europace 2005;7:181-3.
17. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992;15:1667-73.
18. Gradaus R, Block M, Brachmann J, Breithardt G, Huber HG, Jung W et al. Mortality, morbidity, and complications in 3,344 patients with implantable cardioverter defibrillators: results from the German ICD registry EURID. Pacing Clin Electrophysiol 2003;26(Pt I):1511-8.
19. Vollmann D, Lüthje L, Vonhof S, Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm 2005;2:307-9.
20. Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Interv Card Electrophysiol 1998;2:367-70.
21. Babuty D, Fauchier L, Cosnay P. Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphragmatic muscle. Heart 1999;81:94-6.
22. Koul AK, Keller S, Clancy JF, Lampert R, Batsford WP, Rosenfeld LE. Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks. Pacing Clin Electrophysiol 2004;27:681-3.
23. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60.
24. Littmann L, Monroe MH, Kerns WP, Svenson RH, Gallagher JJ. Brugada syndrome and "Brugada sign": clinical spectrum with a guide for the clinician. Am Heart J 2003;145:768-78.
25. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600.
26. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268-72.
27. Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P. Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome. Pacing Clin Electrophysiol 2000;23:410-2.
28. Suzuki H, Torigoe K, Numata O, Yazaki S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:1277-80.
29. Ayerza MR, De Zutter M, Goethals M, Wellens F, Geelen P, Brugada P. Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:943-4.
30. Dinckal MH, Davutoglu V, Akdemir I, Soydinc S, Kirilmaz A, Aksoy M. Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm. Europace 2003;5:257-61.
31. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace 2004;6:13-3.
32. Mok NS, Chan NY, Chiu ACS. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 2004;27(Pt I):821-3.
33. Marquez MF, Rivera J, Hermosillo AG, Iturralde P, Colin L, Moragrega JL et al. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope. Pacing Clin Electrophysiol 2005;28:870-3.
34. Haghjoo M, Arya A, Heidari A, Sadr-Ameli MA. Suppression of electrical storm by oral quinidine in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2005;16:674.
35. Watanabe A, Kusano KF, Morita H, Miura D, Sumida W, Hiramatsu S et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J 2006;27:1579-83.
36. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007;4:695-700.
37. Saxon LA, Shannon K, Wetzel GT, Endler LK, Klitzner TS. Familial long QT syndrome: electrical storm and implantable cardioverter device therapy. Am Heart J 1996;131:1037-9.
38. Takeuchi T, Sato N, Kawamura Y, Takahashi F, Sato M, Kikuchi K et al. A case of a short-coupled variant of torsades de pointes with electrical storm. Pacing Clin Electrophysiol 2003;26(Part I):632-6.
39. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007;4:675-8.
40. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004;43:1843-52.
41. The 2005 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) Science with Treatment Recommendations. Circulation 2005;112:III-1-136.
42. Pinski SL. Emergencies related to implantable cardioverter- defibrillators. Crit Care Med 2000;28(Suppl):N174-80.
43. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
44. Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol 2002;90:853-9.
45. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-90.
46. Mahajan A, Moore J, Cesario DA, Shivkumar K. Use of thoracic epidural anesthesia for management of electrical storm: a case report. Heart Rhythm 2005;2: 1359-62.
47. Russo AM, Beauregard LAM, Waxman HL. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease. Am J Cardiol 1993;72:1395-9.
48. Srivatsa UN, Ebrahimi R, El-Bialy A, Wachsner RY. Electrical storm: case series and review of management. J Cardiovasc Pharmacol Therapeut 2003;8:237-46.
49. Waleffe A, Mary-Rabine L, Legrand V, Demoulin JC, Kulbertus HE. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. Am Heart J 1980;100:788-93.
50. Manolis AG, Katsivas AG, Vassilopoulos C, Tsatiris CG. Electrical storm in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination. J Intervent Cardiac Electrophysiol 2002;6:91-4.
51. Burjorjee JE, Milne B. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anesth 2002;49:973-7.
52. Keeley EC, Hillis LD. Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med 2007;356:47-54.
53. Tanabe Y, Chinushi M, Washizuka T, Minagawa S, Furushima H, Watanabe H et al. Suppression of electrical storm by biventricular pacing in a patient with idiopathic dilated cardiomyopathy and ventricular tachycardia. Pacing Clin Electrophysiol 2003;26(Pt I):101-2.
54. Marketou ME, Simantirakis EN, Manios EG, Vardas PE. Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. Pacing Clin Electrophysiol 2001;24:1827-8.
55. Ben-David J, Zipes DP. Torsades de pointes and proarrhythmia. Lancet 1993;341:1578-82.
56. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-9.
57. Miller RF, Haley MW, Littmann L. Long QT syndrome: first and fatal events provoked by hemodialysis. Pacing Clin Electrophysiol 2003;26(Pt I):103-4.
58. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-72.
59. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392-7.
60. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-9.
61. Dorian P, Mangat I. Role of amiodarone in the era of the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2003;14:S78-81.
62. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES et al. Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. The OPTIC Study: a randomized trial. JAMA 2006;295:165-71.
63. Dijkman B, den Dulk K, Wellens HJJ. Management of electrical instability after ICD implantation. Pacing Clin Electrophysiol 1995;18(Pt II):148-51.
64. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
65. Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G et al. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007;115:2637-41.
66. Korte T, Niehaus M, Meyer O, Tebbenjohanns J. Prospective evaluation of catheter ablation in patients with implantable cardioverter defibrillators and multiple inappropriate ICD therapies due to atrial fibrillation and type I atrial flutter. Pacing Clin Electrophysiol 2001;24:1061-6.
67. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004;109: 1826-33.
68. Leenhardt A, Glaser E, Burguera M, Nürnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes: a new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994;89:206-15.
69. Haïssaguerre M, Shoda M, Jaïs P, Nogami A, Shah DC, Kautzner J et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002;106:962-7.
70. Haïssaguerre M, Extramiana F, Hocini M, Cauchemez B, Jaïs P, Cabrera JA et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003;108:925-8.
71. Bänsch D, Oyang F, Antz M, Arentz T, Weber R, Val-Mejias JE et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003;108:3011-6.
72. Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2004; 43:1715-20.
73. Silva RMFL, Mont L, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27:971-5.
74. Schreieck J, Zrenner B, Deisenhofer I, Schmitt C. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm 2005;2:10-4.
75. Okada T, Yamada T, Murakami Y, Yoshida N, Ninomiya Y, Toyama J. Mapping and ablation of trigger premature ventricular contractions in a case of electrical storm associated with ischemic cardiomyopathy. Pacing Clin Electrophysiol 2007;30:440-3.
76. Littmann L, Svenson RH, Gallagher JJ, Selle JG, Zimmern SH, Fedor JM et al. Functional role of the epicardium in postinfarction ventricular tachycardia: observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation 1991;83:1577-91.
77. Hunt SA. 24th Bethesda Conference: Cardiac Transplantation. J Am Coll Cardiol 1993;22:1-64.
78. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-93.
79. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 2004;33:176-82.
80. Sears SF Jr, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychological considerations for research and clinical care. Clin Cardiol 2003;26:107-11.
81. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 2005;80:232-7.
82. Prudente LA, Reigle J, Bourguignon C, Haines DE, DiMarco JP. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol 2006;15:185-90.
83. Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP et al. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004;27:321-6.
84. Hamner M, Hunt N, Gee J, Garrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics 1999;40:82-5.
85. Maryniak A, Szumowski ,, Walczak F, Derejko P, Bodalski R, Szufladowicz E et al. Post-traumatic stress disorder in a patient with recurrent ICD shocks: the role of RF ablation. Kardiol Pol 2006;64:910-2.
86. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999;9:163-8.
87. Grubb BP. To tame a heart. Pacing Clin Electrophysiol 2007;30:434-5.